Thrombotic microangiopathy after kidney transplantation: causes, clinical specifics and outcomes

Thrombotic microangiopathy after kidney transplantation: causes, clinical specifics and outcomes

Background: Thrombotic microangiopathy (TMA) is a clinical and morphological phenomenon characterized by specific microvascular injury, microangiopathic hemolytic anemia, and damage of various target organs. TMA after kidney transplantation (post-renal transplant TMA) is a serious complication affec...

Full description

Bibliographic Details
Main Authors:	E. I. Prokopenko, E. O. Shcherbakova, R. O. Kantaria, V. A. Stepanov
Format:	Article
Language:	Russian
Published:	MONIKI 2020-10-01
Series:	Alʹmanah Kliničeskoj Mediciny
Subjects:	kidney transplantation thrombotic microangiopathy calcineurin inhibitors toxicity antibody-mediated rejection atypical hemolytic uremic syndrome
Online Access:	https://www.almclinmed.ru/jour/article/view/1296

Similar Items

Characteristics and management of thrombotic microangiopathy in kidney transplantation
by: Wonyong Cho, et al.
Published: (2023-03-01)

Thrombotic microangiopathies: An illustrated review
by: Mouhamed Yazan Abou‐Ismail, et al.
Published: (2022-03-01)

Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
by: Ana Ávila, et al.
Published: (2021-04-01)

A comprehensive model for assessing and classifying patients with thrombotic microangiopathy: the TMA-INSIGHT score
by: Vanessa Vilani Addad, et al.
Published: (2023-11-01)

Pitfalls of Thrombotic Microangiopathies in Children: Two Case Reports and Literature Review
by: Adriana Mocanu, et al.
Published: (2023-03-01)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
by: Sjoerd A. M. E. G. Timmermans, et al.
Published: (2021-07-01)

Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
by: Christopher C. Dvorak, et al.
Published: (2019-04-01)

Clinical case of thrombotic microangiopathy in obstetric practice
by: M. N. Mochalova, et al.
Published: (2017-06-01)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
by: Eleni Gavriilaki, et al.
Published: (2019-02-01)

New in the differential diagnosis of different variants of thrombotic microangiopathies in obstetrics
by: T. V. Kirsanova, et al.
Published: (2021-04-01)

Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review
by: Melody Hermel, et al.
Published: (2020-07-01)

A new pathological perspective on thrombotic microangiopathy
by: Yong-Jin Kim
Published: (2022-09-01)

Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review
by: Marija Malgaj Vrečko, et al.
Published: (2022-09-01)

A novel atypical hemolytic uremic ayndrome – associated CFH gene in a renal transplant recipient complicating ileum perforation
by: Chih-Yu Shen, et al.
Published: (2022-01-01)

Cardiac involvement in thrombotic microangiopathies
by: D S Tuter, et al.
Published: (2015-09-01)

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
by: Tommaso Mazzierli, et al.
Published: (2023-01-01)

Histopathological features of thrombotic microangiopathies in renal biopsies
by: Miguel Ernandes Neto, et al.
Published: (2019-07-01)

The use of eculizumab in gemcitabine induced thrombotic microangiopathy
by: Vinod Krishnappa, et al.
Published: (2018-01-01)

Clinico-Histological Features of Thrombotic Microangiopathy in Renal Biopsies: A Retrospective Study
by: Niraimathi MANICKAM, et al.
Published: (2022-01-01)

MCPggaac haplotype is associated with poor graft survival in kidney transplant recipients with de novo thrombotic microangiopathy
by: Vojtech Petr, et al.
Published: (2022-09-01)

The utility of platelet activation biomarkers in thrombotic microangiopathies
by: Mohammad Al-Tamimi, et al.
Published: (2022-05-01)

Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study
by: Nicolas Henry, et al.
Published: (2021-02-01)

Adrenocortical carcinoma complicated by renal thrombotic microangiopathy, a case-series
by: Tristan de Nattes, et al.
Published: (2020-01-01)

The first successful eculizumab rescue therapy of a kidney transplant recipient with atypical hemolytic uremic syndrome in South Korea: a case report
by: Eun-Ki Min, et al.
Published: (2023-03-01)

Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis
by: Anja Gäckler, et al.
Published: (2021-01-01)

Thrombotic Microangiophatic in the ICU, postpartum hemolytic uremic syndrome: case report
by: Zulma Urbina, et al.
Published: (2016-07-01)

Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature
by: Maryam Saleem, et al.
Published: (2022-05-01)

Drug-induced de novo thrombotic microangiopathy diagnosed 2 years after renal transplantation: a case report and literature review
by: Keisuke Ozaki, et al.
Published: (2023-01-01)

Atypical hemolytic uremic syndrome: a case report
by: B. M. D. B. Basnayake, et al.
Published: (2020-01-01)

Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies
by: Gina Zini, et al.
Published: (2019-11-01)

Severe Acute Kidney Injury in Cardiovascular Surgery: Thrombotic Microangiopathy as a Differential Diagnosis to Ischemia Reperfusion Injury. A Retrospective Study
by: Melissa Grigorescu, et al.
Published: (2020-09-01)

Efficacy of cascade plasmapheresis in comparison with conventional therapeutic plasma exchange for relapsed atypical hemolytic uremic syndrome: A case report
by: Ashwinkumar Vaidya, et al.
Published: (2022-01-01)

Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia
by: Emine Hidayet, et al.
Published: (2022-06-01)

Thrombocytopenia in the ICU: disseminated intravascular coagulation and thrombotic microangiopathies—what intensivists need to know
by: Jean-Louis Vincent, et al.
Published: (2018-06-01)

Transplant-associated Thrombotic Microangiopathy Treated with Eculizumab and Romiplostim
by: Muhammad Awidi, et al.
Published: (2021-02-01)

Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation
by: Zhen Ren, et al.
Published: (2021-11-01)

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies
by: Eszter Trojnar, et al.
Published: (2019-02-01)

Genetic atypical hemolytic uremic syndrome in children: a 20-year experience from a tertiary center
by: Cristiana Maximiano, et al.
Published: (2021-05-01)

A Life-Threating Postpartum Atypical Hemolytic-Uremic Syndrome with Multiorgan Involvement
by: Laura Sarno, et al.
Published: (2022-11-01)

¿Hipertensión arterial maligna con microangiopatía trombótica o nefroangioesclerosis maligna mediada por complemento, evento transitorio o permanente? A propósito de un caso
by: José de la Flor, et al.
Published: (2022-01-01)